Titre : Immunosuppresseurs

Immunosuppresseurs : Questions médicales fréquentes

Termes MeSH sélectionnés :

Polysomnography
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Immunosuppresseurs : Questions médicales les plus fréquentes", "headline": "Immunosuppresseurs : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Immunosuppresseurs : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-27", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Immunosuppresseurs" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Facteurs immunologiques", "url": "https://questionsmedicales.fr/mesh/D007155", "about": { "@type": "MedicalCondition", "name": "Facteurs immunologiques", "code": { "@type": "MedicalCode", "code": "D007155", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs du complément", "alternateName": "Complement Inactivating Agents", "url": "https://questionsmedicales.fr/mesh/D051056", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du complément", "code": { "@type": "MedicalCode", "code": "D051056", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur B2 de la bradykinine", "alternateName": "Bradykinin B2 Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065094", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur B2 de la bradykinine", "code": { "@type": "MedicalCode", "code": "D065094", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.500.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des interleukines", "alternateName": "Interleukin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000088902", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des interleukines", "code": { "@type": "MedicalCode", "code": "D000088902", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.563" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'interleukine-6", "alternateName": "Interleukin-6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000093242", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'interleukine-6", "code": { "@type": "MedicalCode", "code": "D000093242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.594" } } }, { "@type": "MedicalWebPage", "name": "Modulateurs des récepteurs de la sphingosine 1 phosphate", "alternateName": "Sphingosine 1 Phosphate Receptor Modulators", "url": "https://questionsmedicales.fr/mesh/D000081243", "about": { "@type": "MedicalCondition", "name": "Modulateurs des récepteurs de la sphingosine 1 phosphate", "code": { "@type": "MedicalCode", "code": "D000081243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Immunosuppresseurs", "alternateName": "Immunosuppressive Agents", "code": { "@type": "MedicalCode", "code": "D007166", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Koichi Kamei", "url": "https://questionsmedicales.fr/author/Koichi%20Kamei", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan. kamei-k@ncchd.go.jp." } }, { "@type": "Person", "name": "Masao Ogura", "url": "https://questionsmedicales.fr/author/Masao%20Ogura", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan." } }, { "@type": "Person", "name": "Kensuke Shoji", "url": "https://questionsmedicales.fr/author/Kensuke%20Shoji", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan." } }, { "@type": "Person", "name": "Shuichi Ito", "url": "https://questionsmedicales.fr/author/Shuichi%20Ito", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Yokohama City University Hospital, Kanagawa, Japan." } }, { "@type": "Person", "name": "Dorota Iwaszkiewicz-Grześ", "url": "https://questionsmedicales.fr/author/Dorota%20Iwaszkiewicz-Grze%C5%9B", "affiliation": { "@type": "Organization", "name": "Department of Medical Immunology, Faculty of Medicine, Medical University of Gdansk, ul. Dębinki 7, 80-210 Gdańsk, Poland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "External proficiency testing improves inter-scorer reliability of polysomnography scoring.", "datePublished": "2022-07-29", "url": "https://questionsmedicales.fr/article/35902534", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11325-022-02673-4" } }, { "@type": "ScholarlyArticle", "name": "Polysomnography in hospitalized children: Characteristics and clinical practice at a single tertiary care center.", "datePublished": "2023-06-28", "url": "https://questionsmedicales.fr/article/37378456", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ppul.26567" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of the Heart Rhythm Coherence Ratio During Sleep: A Pilot Study With Polysomnography.", "datePublished": "2022-05-03", "url": "https://questionsmedicales.fr/article/35503195", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10484-022-09542-6" } }, { "@type": "ScholarlyArticle", "name": "Factors affecting polysomnography compliance and delays to surgical treatment of obstructive sleep apnea.", "datePublished": "2023-06-17", "url": "https://questionsmedicales.fr/article/37348250", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijporl.2023.111637" } }, { "@type": "ScholarlyArticle", "name": "Characteristics of salivary microbiota in children with obstructive sleep apnea: A prospective study with polysomnography.", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36105146", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcimb.2022.945284" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Effets physiologiques des médicaments", "item": "https://questionsmedicales.fr/mesh/D045505" }, { "@type": "ListItem", "position": 5, "name": "Facteurs immunologiques", "item": "https://questionsmedicales.fr/mesh/D007155" }, { "@type": "ListItem", "position": 6, "name": "Immunosuppresseurs", "item": "https://questionsmedicales.fr/mesh/D007166" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Immunosuppresseurs - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Immunosuppresseurs", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Immunosuppresseurs", "description": "Comment diagnostiquer une nécessité d'immunosuppresseurs ?\nQuels tests sont utilisés pour évaluer l'immunité ?\nQuels signes indiquent un besoin d'immunosuppresseurs ?\nComment évaluer le risque de rejet d'organe ?\nQuels symptômes nécessitent un traitement immunosuppresseur ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Polysomnography&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Immunosuppresseurs", "description": "Quels sont les effets secondaires des immunosuppresseurs ?\nComment reconnaître une infection due à l'immunosuppression ?\nQuels symptômes d'allergie peuvent survenir ?\nLes immunosuppresseurs causent-ils des troubles digestifs ?\nQuels signes indiquent une réaction indésirable ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Polysomnography&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Immunosuppresseurs", "description": "Comment prévenir les infections sous immunosuppression ?\nQuelles précautions alimentaires prendre ?\nComment gérer le stress pendant le traitement ?\nQuels examens de suivi sont nécessaires ?\nComment éviter les interactions médicamenteuses ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Polysomnography&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Immunosuppresseurs", "description": "Quels types d'immunosuppresseurs existent ?\nComment sont administrés les immunosuppresseurs ?\nQuelle est la durée du traitement immunosuppresseur ?\nComment ajuster la posologie des immunosuppresseurs ?\nQuels sont les traitements alternatifs aux immunosuppresseurs ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Polysomnography&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Immunosuppresseurs", "description": "Quelles sont les complications possibles des immunosuppresseurs ?\nComment reconnaître une infection grave ?\nLes immunosuppresseurs augmentent-ils le risque de cancer ?\nQuels troubles métaboliques peuvent survenir ?\nComment gérer les complications liées aux immunosuppresseurs ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Polysomnography&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Immunosuppresseurs", "description": "Quels facteurs augmentent le besoin d'immunosuppresseurs ?\nComment l'âge influence-t-il le traitement ?\nLe mode de vie affecte-t-il l'immunosuppression ?\nQuels médicaments augmentent le risque d'interactions ?\nLes antécédents familiaux influencent-ils le traitement ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Polysomnography&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une nécessité d'immunosuppresseurs ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique et des tests sanguins pour évaluer l'auto-immunité." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'immunité ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme le dosage des anticorps et des lymphocytes T sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent un besoin d'immunosuppresseurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des inflammations chroniques ou des éruptions cutanées peuvent indiquer ce besoin." } }, { "@type": "Question", "name": "Comment évaluer le risque de rejet d'organe ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par des tests de compatibilité et des marqueurs immunologiques." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un traitement immunosuppresseur ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue extrême ou des douleurs articulaires peuvent nécessiter un traitement." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des immunosuppresseurs ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent infections, fatigue, et troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Comment reconnaître une infection due à l'immunosuppression ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme fièvre, frissons ou douleurs inhabituelles peuvent indiquer une infection." } }, { "@type": "Question", "name": "Quels symptômes d'allergie peuvent survenir ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons ou gonflements peuvent être des signes d'allergie." } }, { "@type": "Question", "name": "Les immunosuppresseurs causent-ils des troubles digestifs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nausées, vomissements ou diarrhées peuvent survenir avec certains immunosuppresseurs." } }, { "@type": "Question", "name": "Quels signes indiquent une réaction indésirable ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs abdominales ou des saignements peuvent signaler une réaction." } }, { "@type": "Question", "name": "Comment prévenir les infections sous immunosuppression ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de se faire vacciner et d'éviter les contacts avec des personnes malades." } }, { "@type": "Question", "name": "Quelles précautions alimentaires prendre ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments crus et assurez-vous que les aliments sont bien cuits pour prévenir les infections." } }, { "@type": "Question", "name": "Comment gérer le stress pendant le traitement ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de relaxation et un soutien psychologique peuvent aider à gérer le stress." } }, { "@type": "Question", "name": "Quels examens de suivi sont nécessaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers de la fonction rénale et des tests sanguins sont nécessaires pour le suivi." } }, { "@type": "Question", "name": "Comment éviter les interactions médicamenteuses ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Informez toujours votre médecin de tous les médicaments que vous prenez pour éviter les interactions." } }, { "@type": "Question", "name": "Quels types d'immunosuppresseurs existent ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux types incluent les corticostéroïdes, les inhibiteurs de calcineurine et les agents biologiques." } }, { "@type": "Question", "name": "Comment sont administrés les immunosuppresseurs ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être administrés par voie orale, intraveineuse ou sous-cutanée selon le médicament." } }, { "@type": "Question", "name": "Quelle est la durée du traitement immunosuppresseur ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La durée varie selon la maladie, allant de quelques mois à plusieurs années." } }, { "@type": "Question", "name": "Comment ajuster la posologie des immunosuppresseurs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La posologie est ajustée en fonction des résultats des tests sanguins et de la réponse clinique." } }, { "@type": "Question", "name": "Quels sont les traitements alternatifs aux immunosuppresseurs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs incluent des thérapies biologiques et des médicaments anti-inflammatoires." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des immunosuppresseurs ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections graves, des cancers et des troubles métaboliques." } }, { "@type": "Question", "name": "Comment reconnaître une infection grave ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme une forte fièvre, des frissons ou une confusion peuvent indiquer une infection grave." } }, { "@type": "Question", "name": "Les immunosuppresseurs augmentent-ils le risque de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation prolongée d'immunosuppresseurs peut augmenter le risque de certains cancers." } }, { "@type": "Question", "name": "Quels troubles métaboliques peuvent survenir ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles comme le diabète ou l'hypertension peuvent survenir avec certains immunosuppresseurs." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux immunosuppresseurs ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi régulier, des ajustements de traitement et une surveillance des symptômes." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin d'immunosuppresseurs ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de maladies auto-immunes ou de transplantation augmentent ce besoin." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le traitement ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent avoir un risque accru d'effets secondaires et nécessiter des ajustements." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il l'immunosuppression ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire les risques d'infections et améliorer la réponse au traitement." } }, { "@type": "Question", "name": "Quels médicaments augmentent le risque d'interactions ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certains antibiotiques et antifongiques peuvent interagir avec les immunosuppresseurs." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le traitement ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies auto-immunes peuvent augmenter le risque de développer des maladies similaires." } } ] } ] }

Sources (849 au total)

External proficiency testing improves inter-scorer reliability of polysomnography scoring.

This study evaluated whether or not polysomnography (PSG) inter-scorer reliability (ISR) across sleep centres could be improved by external proficiency testing (EPT), or by EPT combined with method al... Experienced scorers form 15 sleep centres were randomised to the following: (1) a control group, (2) a group that received a self-directed intervention of EPT reports (EPT... Among 30 scorers, there were no ISR changes in controls between baseline (BL) and 6 months (6 m). Both EPT groups showed ISR improvement from BL to 6 m for respiratory, arousal and sleep scoring (p < ... External proficiency testing produced modest, statistically significant PSG inter-scorer reliability improvements among experienced scorers across sleep centres, with potential to improve clinical man...

Polysomnography in hospitalized children: Characteristics and clinical practice at a single tertiary care center.

Polysomnography (PSG) is the gold standard for the diagnosis of pediatric sleep-disordered breathing (SDB). However, the literature characterizing the indications for inpatient PSGs and the impact on ... To determine the indications, results, and outcomes for children undergoing inpatient PSGs at our institution.... We performed a retrospective review of children aged 0-18 years who underwent inpatient diagnostic PSGs between July 2018 and July 2021 at SickKids, Toronto, Canada. Baseline characteristics, indicati... Eighty-eight inpatient PSGs were performed in 75 children (male 62.7%). Median (interquartile range) age and body mass index z-score were 1.5 (0.2, 10.8) years and 0.27 (-1.58, 2.66), respectively. Th... Our study highlights that inpatient PSG was an important diagnostic tool resulting in directed medical and surgical management. Future multicenter studies are needed to compare indications for inpatie...

Factors affecting polysomnography compliance and delays to surgical treatment of obstructive sleep apnea.

To evaluate adherence to polysomnography in pediatric patients and determine if demographics, socioeconomic status, polysomnography indication, or prior otolaryngology intervention are associated with... Retrospective review study.... Tertiary-care children's hospital.... Electronic medical record was queried to identify patients ordered for a sleep study between January and May 2019. Demographic information, time to sleep study, and time to surgery were collected and ... 304 patients were recommended to obtain polysomnography, with adherence rate of 65.4%. There was no significant difference in adherence or loss to follow-up rates based on patient sex, age, language, ... Families with lower socioeconomic status or medically complex children may require assistance to obtain polysomnography and pursue surgery for sleep-disordered breathing. Patients without prior otolar...

Characteristics of salivary microbiota in children with obstructive sleep apnea: A prospective study with polysomnography.

The present study aimed to investigate the characteristics of salivary microbiota of children with obstructive sleep apnea (OSA) and to assess longitudinal alterations in salivary microbiota before an... A set of cross-sectional samples consisted of 36 OSA children (17 boys and 19 girls, 7.47 ± 2.24 years old) and 22 controls (9 boys and 13 girls, 7.55 ± 2.48 years old) were included in the study, amo... In cross-sectional samples, the OSA group had higher α-diversity as estimated by Chao1, Shannon, Simpson, Pielou_e, and observed species as compared with the control group (... A significantly higher microbial diversity and a significant difference in microbial composition and abundance were identified in salivary microbiota of OSA children compared with controls. Meanwhile,...

Polysomnography findings in preschool children with obstructive sleep apnea are affected by growth and developmental level.

We investigated the effect of growth and development level on polysomnography results in preschool children with obstructive sleep apnea (OSA).... Preschool children (ages 3-6) with symptoms of snoring and were diagnosed with OSA by polysomnography in the sleep center were selected as the research object. They were split into three groups based ... A total of 183 (111 boys and 72 girls) preschool children were enrolled. There were 26 cases in the growth restricted group, 112 cases in the normal growth group, and 45 cases in the overgrowth group.... OSA is more likely in preschool-aged children with stunted or overgrown growth than in children with OSA alone, and the more severe the disorder, especially when accompanied with stunted growth....

Feasibility of split night polysomnography in children to diagnose and treat sleep related breathing disorders.

The gold standard test for diagnosis of sleep related breathing disorders (SRBD) in children is diagnostic polysomnography (PSG). This is often followed by a titration PSG to identify optimal non-inva... This multi-center study analyzed clinical and PSG data from children with SRBD who had initiated NIV following a snPSG. Data from diagnostic and titration portions of the snPSG were analyzed separatel... The study included 165 children who initiated NIV following a snPSG. The majority of children (61.8%) were initiated on NIV for upper airway obstruction. The population included children with medical ... snPSG is technically feasible in children, facilitating the diagnosis of SRBD and initiation of NIV, even in those with high medical complexity....

Exploration of sleep disturbances in children and adolescents with and without autism in a paediatric sample referred for polysomnography.

The purpose of the study was to increase the body of knowledge related to sleep in children with autism. The specific aims were to (i) identify the subgroup of children with autism, ages 3-17 years, r... The authors performed a secondary data analysis of the de-identified Nationwide Children's Hospital Sleep DataBank, a collection of encounters with children referred for polysomnography. The data were... In the sample, there were 2838 unique participants (M = 10.5 years) with a total of 172 167 encounters between 2017 and 2019. Of these, 198 (7%) were diagnosed with Autism Spectrum Disorder, Asperger'... Findings elucidate the increased presence of sleep problems in paediatric patients with autism, and the need for purposeful sleep evaluation and research given the potential impact on daytime function...

Cost-minimisation analysis of polysomnography and pulse oximetry in a risk stratification protocol for paediatric adenotonsillectomy.

Severe obstructive sleep apnoea (OSA) is associated with increased risk of respiratory compromise in the post-operative period following adenotonsillectomy (AT). This study analyses the economic cost ... This cost-minimisation analysis examines costs associated with pre-operative overnight oximetry and polysomnography in triaging paediatric patients older than 2 years old, with no major comorbidities ... The total cost per patient of AT including pre-operative investigations of oximetry and polysomnography, and associated inpatient costs, were AUD4181.34 and 5013.99 respectively. This is more expensiv... Within the scope of this partial economic evaluation, this study finds a small additional cost for a model of care involving overnight oximetry as a pre-operative triage tool, balanced by the reduced ...